Continuous cell culture system with double columns connected in series, culture process and application
Through the dual-column tandem cell continuous culture system and recycling culture medium, the problem of difficult clarification of biological products in high-density cell culture and unstable quality in high-temperature environments is solved, the protein yield and quality maintenance is achieved, and the production cost is reduced. Purification pressure.
Patent Information
- Application Number
- CN202411212470.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-26
AI Technical Summary
In existing biopharmaceuticals, high-density cell culture makes it difficult to clarify the mixture of biological products and cells, the purification process pressure is high, and the quality of biological products is unstable in high-temperature and complex environments. The use of culture medium under the traditional perfusion culture mode is large and the cost is high. And it is difficult to effectively utilize reflux culture medium.
Using a two-column tandem cell continuous culture system, the cells and target products are intercepted using the first and second-level filter columns, protein collection and storage are carried out through an external harvesting container, and temperature and additives are controlled to improve protein quality and stability. And reduce the use of fresh medium by recycling the medium.
It realizes the maintenance of protein yield and quality in long-term culture, reduces downstream purification pressure, reduces production costs, improves protein yield and stability, optimizes the reuse of culture medium, and reduces the use of fresh culture medium .
Smart Images

Figure CN119020164A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biopharmaceuticals, and in particular relates to a double-column series continuous cell culture system and a culture process and application. Background Art
[0002] The demand for biopharmaceuticals, especially therapeutic recombinant proteins, continues to grow. The production process of recombinant proteins or other biological products is a complex task, usually using traditional fed-batch culture processes or perfusion continuous culture processes.
[0003] There are currently different types of perfusion processes. For example, in a typical perfusion culture process, cells are cultured for a long time by continuously adding fresh culture medium to the cells and discharging the cells to maintain high cell viability. In a typical perfusion cell culture process, the biological products secreted by the cells are continuously harvested during the cell culture or are continued to be retained in the bioreactor. A perfusion process with ultra-high cell concentration is provided in the prior art, in which biological substances and cells circulate in a separation system, wherein the biological substances are retained in the reactor or intercepted back into the reactor, and the product is harvested when the culture is terminated. After harvesting, the high-density cell packed volume (PCV) makes it difficult to clarify the mixture of cells and biological products. The high-density cell packed volume puts a lot of pressure on the downstream purification process, especially the clarification and filtration step, and will also result in a lower overall yield. At the same time, biological products are in a high temperature and complex cell culture environment (in a cell culture container) for a long time, which may be detrimental to the stability of the quality of biological products.
[0004] For high-density culture systems, if the product is retained in the bioreactor, especially for polyantibodies, fusion proteins, enzymes, etc., its purity or other quality attributes are likely to be unstable. Therefore, the cell culture process still needs to be improved to increase product yield, improve product quality and reduce the complexity of production operations.
[0005] Therefore, a series of new methods are needed to allow all biological substances to be trapped in external containers during production. This method can better separate the target protein, thereby reducing the pressure of downstream purification and improving the yield of the protein; at the same time, a better environment can be provided for the target product, including storage temperature, additives, buffer system, etc. The external container can improve or adjust the quality of the protein and maintain the stability of the protein and protein quality during long-term culture and storage.
[0006] The perfusion culture mode requires a continuous supply of culture medium to provide the required nutrients for the cells, and uses a filter device to intercept substances (including cells) larger than the side aperture of the filter device and return them to the reaction system, while discharging substances (including cell debris, metabolic waste, etc.) smaller than the side aperture of the filter device. This can provide a good growth environment for cells, in which the cell density and protein production are significantly improved. However, in this culture mode, the amount of fresh culture medium used is large, and the cost of culture medium is greatly increased. Therefore, it has become a topic of concern to study whether the cell fluid passed through the filter device can be reused by cells. For example, in another prior art, a culture medium reflux method is disclosed, and it is proved that this reflux method is feasible based on a large number of experiments, but there are many problems. For example, when the pore size of the secondary filter membrane is large, the refluxed culture medium has a high osmotic pressure and contains more cell debris and metabolic waste, which may cause the cell diameter to become larger or die. When the pore size of the secondary filter membrane is small, the refluxed culture medium is lacking in nutrients, and the environment in which the cells are located deteriorates, resulting in a decrease in the ability of the cells to produce protein. In this case, in order to maintain the production of cells, the proportion of feed is usually greatly increased. As we all know, in cell culture, the price of feed medium is much more expensive than that of basal medium. As the amount of medium used increases, the production cost of antibodies becomes higher. Therefore, it is necessary to optimize the used medium so that the medium can be reused to achieve the purpose of cost saving.
[0007] In summary, it is necessary to find new methods for the reuse of culture medium, optimize the osmotic pressure and nutrient composition of the reused culture medium, and reduce the amount of feed culture medium used to further save production costs. Summary of the invention
[0008] In view of the shortcomings of the prior art, the purpose of the present invention is to provide a double-column series continuous cell culture system and culture process and application. The present invention provides an improved cell culture process that can maintain long-term culture of each batch and maintain a better protein yield based on long-term culture, and can also maintain a better protein quality.
[0009] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0010] In a first aspect, the present invention provides a double-column series-connected continuous cell culture system, the culture system comprising:
[0011] A cell culture container, wherein the cell culture container is used for cell culture;
[0012] A first-stage filter column, comprising a first-stage filter membrane, wherein the pore size of the first-stage filter membrane is smaller than the diameter of the cells and larger than the diameter of the target product expressed by the cells; the pore size of the first-stage filter membrane is 0.1-20 μm;
[0013] The second-stage filter column has a second-stage filter membrane, the pore size of which is smaller than the diameter of the target product expressed by the cells; the second-stage filter membrane is an ultrafiltration membrane, and the pore size of which is 0-100KD;
[0014] A harvest container is provided between the first-stage filter column and the second-stage filter column, the harvest container is used to store components that have passed through the first-stage filter membrane and have not passed through the second-stage filter membrane, and the second-stage filter membrane performs membrane separation treatment on the suspension extracted from the harvest container; a temperature control device and a first sterile feed flow path are provided on the harvest container; the first sterile feed flow path is used to add additives to the harvest container;
[0015] The culture system further comprises: a first liquid storage container, a second liquid storage container or a third liquid storage container, or a combination thereof;
[0016] The third liquid storage container is used to store the components that pass through the second-stage filtration membrane; the third liquid storage container is provided with a second sterile feed flow path, and the second sterile feed flow path is used to add nutrients to the third liquid storage container.
[0017] In the present invention, the nutrients are components necessary for cell growth and fermentation, and are adaptively adjusted according to the type of cells during specific practice.
[0018] In the present invention, the first filter membrane performs membrane separation treatment on the cell suspension extracted from the cell culture container; the components blocked by the first filter membrane are returned to the cell culture container; and the components that pass through the first filter membrane are stored in the harvest container. The second filter membrane performs membrane separation treatment on the suspension extracted from the harvest container; all the components blocked by the second filter membrane are retained in the harvest container; and the components that pass through the second filter membrane are stored as a recycled culture medium.
[0019] The present invention uses two hollow fiber columns connected in series, so that the cells can continuously receive fresh culture medium and the addition of nutrients, and the culture medium after cell utilization can be continuously discharged, and all target products are collected in an external collection device through the different pore sizes of the two columns. The culture system of the present invention can maintain long-term culture of each batch and maintain better protein yield and quality based on long-term culture.
[0020] One of the biggest advantages of the cell culture process of the present invention is that it has an external biological product collection device, which has significant advantages over other processes and has achieved some effects of regulating the quality of the target protein according to experimental data. According to the characteristics of the protein and the support of stability experimental data, the external harvesting container can be placed in an environment and temperature that is more conducive to the stability and long-term preservation of the target protein. This method can improve the quality of the protein and extend the cell culture time, especially for polyclonal antibodies, fusion proteins, enzymes, etc., which have low purity and are extremely unstable, thereby increasing the yield of the protein.
[0021] Preferably, the temperature of the harvesting container is controlled at 2-18°C, for example, it can be 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C, 13°C, 14°C, 15°C, 16°C, 17°C or 18°C, etc.
[0022] In the present invention, the harvest container is placed in an environment of 2-18°C, including but not limited to a refrigerator, a cold storage, and a liquid storage bottle; in large-scale production, the harvest container can also be placed in a sterile container that can store liquids, such as a culture tank / seed tank / liquid storage tank, and condensed water and a temperature electrode in the tank can also be used for precise temperature control.
[0023] Preferably, the membrane separation treatment is carried out in a tangential flow manner.
[0024] Preferably, the additive comprises: any one of a protective agent, a neutral buffer system, an acidic buffer system, an alkaline buffer system or an amino acid, or a combination of at least two thereof.
[0025] Preferably, the protective agent is selected from any one or a combination of at least two of salt ions such as sucrose, PS80, P188, sodium salt, sulfate or ammonium salt.
[0026] Preferably, the neutral buffer system is PB.
[0027] Preferably, the acidic buffer system is selected from citric acid or acetic acid.
[0028] Preferably, the alkaline buffer system is selected from Tris systems such as Tris-Hac or Tris-HCl.
[0029] Preferably, the amino acid is selected from arginine or histidine.
[0030] In the present invention, the external biological product collection device has significant advantages over other patents. In addition to temperature control, some additives can be added to the harvest container through the first sterile feed flow path. The time of addition can be considered according to the purpose of the added additives. It can be added before starting pump 2, during the culture process, or at the end of the culture. Additives include but are not limited to: metal ions, trace elements, amino acids, etc. It can protect proteins from oxidation and reduction, and can adjust the quality of proteins, such as: protein purity and charge heterogeneity distribution.
[0031] Before installing the harvest container, adding some buffer or auxiliary materials to the harvest container is beneficial to the long-term storage of protein and protects the protein quality from changes with temperature, protein concentration, and time. Buffers include different types of salt ions and different pH and auxiliary materials. Buffers and auxiliary materials include but are not limited to: pH 2.5-10.0, HCl, HAC, Tris, Na + , SO4 2- , NH4 + , HPO4 2+ , Citric, EDTA, methionine, glycerol, sucrose, arginine, etc.
[0032] Preferably, the first liquid storage container is used to store fresh culture medium.
[0033] Preferably, the first liquid storage container is connected to the cell culture container via a first flow path, and the flow rate is controlled by a pump.
[0034] Preferably, the second liquid storage container is used to store recycled culture medium.
[0035] Preferably, the second liquid storage container is connected to the cell culture container via a fourth flow path, and the flow rate is controlled by a pump four.
[0036] Preferably, the nutrient components include any one or a combination of at least two of carbohydrates, P188, CB5, glutamine, glutamic acid, HT, amino acids, metal ions, lipid precursors, nucleic acid precursors, pH buffers or cell protectants.
[0037] Preferably, the cell protectant is selected from PEG or a nonionic surfactant.
[0038] Preferably, the cell culture container is provided with a regulating flow path, and the regulating flow path is used to regulate the cell density and viability in the cell culture container.
[0039] Preferably, a scale is provided below the cell culture container; the scale is used to control the total amount of the culture in the cell culture container.
[0040] In the present invention, the scale can be associated with pump two and pump three to control the volume of liquid in the cell culture container and / or the harvest container.
[0041] Preferably, the cell culture container is connected to the first-stage filtration column via a first circulation flow path.
[0042] Preferably, the first circulation flow path is used to transport the cell suspension from the cell culture container to the first-stage filtration column, and to return the components blocked by the first-stage filtration membrane to the cell culture container.
[0043] Preferably, the first-stage filtration column is connected to the harvesting container via a second flow path, and the flow rate is controlled by pump 2.
[0044] Preferably, the harvest container is connected to the second-stage filtration column via a second circulation flow path.
[0045] Preferably, the second circulation flow path is used to transport the suspension from the harvest container to the second-stage filtration column, and to return the components rejected by the second-stage filtration membrane to the harvest container.
[0046] Preferably, the second-stage filter column is connected to the third liquid storage container via a third flow path, and the flow rate is controlled by a third pump.
[0047] In a second aspect, the present invention provides a double-column series continuous cell culture process, the culture process comprising:
[0048] The cells are inoculated into a cell culture container for continuous perfusion culture;
[0049] The first-stage filtration membrane separation process is started, and the cell suspension extracted from the cell culture container is subjected to membrane separation treatment using the first-stage filtration membrane, and the components blocked by the first-stage filtration membrane are returned to the cell culture container; the components that pass through the first-stage filtration membrane are stored in a harvest container; the pore size of the first-stage filtration membrane is smaller than the diameter of the cell and larger than the diameter of the target product expressed by the cell; the pore size of the first-stage filtration membrane is 0.1-20 μm;
[0050] The temperature of the harvest container is controlled by a temperature control device, and the additive is added to the harvest container through the first sterile feed flow path;
[0051] The second-stage filtration membrane separation process is started, and the suspension extracted from the harvest container is subjected to membrane separation treatment using the second-stage filtration membrane, components blocked by the second-stage filtration membrane are returned to the harvest container, and components passing through the second-stage filtration membrane are stored as recycled culture medium; the membrane pore size of the second-stage filtration membrane is smaller than the diameter of the target product expressed by the cells; the second-stage filtration membrane is an ultrafiltration membrane, and the membrane pore size of the second-stage filtration membrane is 0-100KD.
[0052] The present invention proposes a new double-column series culture method, which allows all biological substances to be trapped in an external harvesting container during production. Through this method, the target product is better separated, thereby reducing the pressure of downstream purification and increasing the protein yield. It can also provide a better environment for the target product, including storage temperature, additives, buffer system, etc., which can improve or adjust the quality of the protein and maintain the stability of the protein during long-term culture and storage. This method has a large application scenario for projects with certain quality problems of fusion proteins, enzymes, polyclonal antibodies, etc. and unstable target proteins.
[0053] Preferably, when the working volume of the cell culture container is larger than the initial culture volume, the first stage filtration membrane separation process is started.
[0054] Preferably, when the liquid volume in the harvest container reaches 0.5-2 working volumes, the second-stage filtration membrane separation process is started; wherein 0.5-2 working volumes can be, for example, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2, etc.
[0055] Preferably, the ambient temperature of the harvesting container is controlled to be 2-18°C, for example, it can be 2°C, 3°C, 4°C, 5°C, 6°C, 7°C, 8°C, 9°C, 10°C, 11°C, 12°C, 13°C, 14°C, 15°C, 16°C, 17°C or 18°C, etc.
[0056] Preferably, the membrane separation treatment is carried out in a tangential flow manner.
[0057] In the present invention, the membrane separation treatment method is a tangential flow method, and the membrane separation technology can be achieved by using the ATF / TFF operating system for control.
[0058] Preferably, the additive comprises: any one of a protective agent, a neutral buffer system, an acidic buffer system, an alkaline buffer system or an amino acid, or a combination of at least two thereof.
[0059] Preferably, the protective agent is selected from any one or a combination of at least two of salt ions such as sucrose, PS80, P188, sodium salt, sulfate or ammonium salt.
[0060] Preferably, the neutral buffer system is PB.
[0061] Preferably, the acidic buffer system is selected from citric acid or acetic acid.
[0062] Preferably, the alkaline buffer system is selected from Tris-Hac or Tris-HCl.
[0063] Preferably, the amino acid is selected from arginine or histidine.
[0064] Preferably, the concentration of the target product in the harvesting container is controlled by:
[0065] The working speed of the pump in the second-stage filtration membrane separation process is controlled to be greater than that in the first-stage filtration membrane separation process, and the concentration of the target product in the harvest container increases;
[0066] Or, the working speed of the pump in the second-stage filtration membrane separation process is controlled to be lower than that in the first-stage filtration membrane separation process, so that the concentration of the target product in the harvest container is reduced;
[0067] After the concentration of the target product reaches the desired concentration, the working speed of the pump in the second-stage filtration membrane separation process is controlled to be equal to that in the first-stage filtration membrane separation process to keep the volume of the suspension in the harvest container constant.
[0068] In one specific embodiment, a method for increasing the concentration of protein in a harvest container is to adjust pump three to an automatic mode after a certain period of culturing, and set a fixed value that is greater than or much greater than the working rate of pump two. The time of the automatic operation mode of pump three can be flexibly set according to the required protein concentration. When the required protein concentration is reached, the automatic operation mode can be turned off and the original mode associated with the scale below the bioreactor can be changed back to maintain a constant volume of the suspension in the harvest container. This method adjusts the protein concentration by changing the volume of the liquid in the harvest container. This method is often used when the protein yield is low.
[0069] In one specific embodiment, the concentration of protein in the harvest container is reduced, and after a certain period of culture, pump three is adjusted to automatic mode and a fixed value is set, which is less than or much less than the working rate of pump two. The time of the automatic operation mode of pump three can be flexibly set according to the required protein concentration. When the required protein concentration is reached, the automatic operation mode can be turned off and the original mode associated with the scale below the bioreactor can be changed back to maintain a constant volume of the suspension in the harvest container. This method adjusts the protein concentration by changing the liquid volume in the harvest container. This method is often used on the day of harvest or 2-3 days before harvest to reduce the purification pressure and risks downstream due to column load limitations.
[0070] The present invention creatively designs a control process, and the existing solutions lack such a feedback control solution that can control the concentration of the target product. The solution of the present invention has important application prospects in cell culture.
[0071] Preferably, the perfusion medium used in the perfusion continuous culture is fresh medium or a combination of fresh medium and recycled medium.
[0072] Preferably, in the first culture cycle, the perfusion continuous culture is perfused with fresh culture medium; from the second culture cycle to the end of the culture, the perfusion continuous culture is performed with a combination of fresh culture medium and recycled culture medium.
[0073] Preferably, when a combination of fresh culture medium and recycled culture medium is used for perfusion continuous culture, the perfusion rate ratio of fresh culture medium to recycled culture medium in the first cycle is (1:9)-(5:5); the perfusion rate ratio in the second cycle is (2:8)-(7:3); and the perfusion rate ratio in the third cycle is (3:7)-(9:1).
[0074] Among them, (1:9)-(5:5) can be, for example, 1:9, 2:8, 3:7, 4:6 or 5:6, etc.; (2:8)-(7:3) can be, for example, 2:8, 3:7, 4:6, 5:5, 6:4 or 7:3, etc.; (3:7)-(9:1) can be, for example, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2 or 9:1, etc.
[0075] In the present invention, when a combination of fresh culture medium and recycled culture medium is used for perfusion continuous culture, the perfusion rate ratio of the fresh culture medium to the recycled culture medium is set based on the number of cycles of the recycled culture medium.
[0076] In the present invention, the perfusion rate of the perfusion medium is 0.1-4 working volumes / day, for example, it can be 0.1, 0.2, 0.4, 0.6, 0.8, 1, 1.2, 1.4, 1.6, 1.8, 2, 2.2, 2.4, 2.6, 2.8, 3, 3.2, 3.4, 3.6, 3.8 or 4, etc.
[0077] Preferably, nutrients are also added to the recycling culture medium.
[0078] In the present invention, the nutrient components necessary for cells are also added to the recycling culture medium, which are selected according to the adaptability of the cell type in specific practice.
[0079] Preferably, the nutrient components include any one or a combination of at least two of carbohydrates, P188, CB5, glutamine, glutamic acid, HT, amino acids, metal ions, lipid precursors, nucleic acid precursors, pH buffers or cell protectants.
[0080] Preferably, the cell protectant is selected from PEG or a nonionic surfactant.
[0081] Preferably, the amount of the nutrients added is calculated based on the volume of the circulating culture medium.
[0082] The present invention provides several methods for recycling culture medium in batches, which have great advantages over the patents that have been published for directly using culture liquid from a secondary filter membrane. The method of the present invention can avoid the disadvantages of the prior art, such as: as the culture time increases, the cell state gradually deteriorates, and metabolic wastes will increase. Using such liquid directly back into the tank for cell use will limit the growth of cells and protein production. Using the method of recycling in batches provided in the present invention, the ratio of circulating culture medium to fresh culture medium can be adjusted according to the different culture time periods, so as to ensure that the production of cells and protein production are no different from those of fresh culture medium. At the same time, according to the different culture time periods, different proportions of necessary nutrients required for cell culture can also be added to the recycled culture medium. By adopting the method of recycling culture medium in batches provided by the present invention, not only can the cost of cell culture be reduced, but also the state of cells, metabolism, and the yield and quality of target protein can be ensured to be no significantly different from those of fresh culture medium.
[0083] Preferably, the initial density of cells inoculated in the cell culture container is in the range of (0.1-4.0)×10 6 viable cells / mL.
[0084] Preferably, the method further comprises adding a defoaming agent into the bioreactor before the inoculation or during the culturing process.
[0085] In the present invention, before inoculation or during the culture process, when foam accumulates, an appropriate amount of defoaming agent can be added to the bioreactor to alleviate cell damage caused by bubble bursting during the culture period.
[0086] Preferably, 0-120 ppm of defoaming agent is added every day during the perfusion continuous culture process, for example, 10 ppm, 20 ppm, 40 ppm, 60 ppm, 80 ppm, 100 ppm or 120 ppm.
[0087] Preferably, when the oxygen flow rate reaches 0.3-0.8VVM during the perfusion continuous culture process, a differentiator is used for control; wherein 0.3-0.8VVM can be, for example, 0.3VVM, 0.4VVM, 0.5VVM, 0.6VVM, 0.7VVM or 0.8VVM, etc.
[0088] Preferably, the cells are allowed to flow out of the cell culture container by adjusting the flow path based on the density of the cells and the viability of the cells in the cell culture container.
[0089] The density and viability of the cells in the cell culture container of the present invention are set based on the type of cells being cultured.
[0090] For example, in one embodiment, the cell density is greater than (30-80)×10 6 When the cell density in the cell culture container is greater than (20-30)×10 6 When the cell density in the cell culture container is greater than (80-200)×10 6 When the concentration of live cells / mL is 100,000, the flow path is adjusted to allow the cells to flow out of the cell culture container, thereby maintaining the cell density in the cell culture container within an appropriate range.
[0091] For example, in one embodiment, when the cell viability is less than 95%-98%, the flow path is adjusted to allow the cells to flow out of the cell culture container, thereby maintaining the cell viability in the cell culture container within a suitable range; for example, in another embodiment, when the cell viability is less than 80%-95%, the flow path is adjusted to allow the cells to flow out of the cell culture container, thereby maintaining the cell viability in the cell culture container within a suitable range. Preferably, the harvest container and the flow path connected to the harvest container are sterile sealed, and after the new harvest container and the corresponding flow path are replaced, the harvest container is directly connected to the downstream processing process.
[0092] Preferably, the harvest container is a sterile container that can store liquid.
[0093] Preferably, the types of the harvest container include: liquid storage tank, culture tank, sterile bottle or sterile bag, etc.
[0094] In the present invention, the product in the harvesting container can be harvested in batches according to the loading capacity requirement of the downstream filler.
[0095] In the perfusion culture mode of the present invention, the protein yield that can be obtained is usually large. Giving all the harvested proteins to the downstream at one time at the end of the culture will cause the workload and filler loading of the downstream to be overloaded. The culture mode of the present invention can be used to give the protein product to the downstream for corresponding purification work when the protein amount reaches the demand or the filler loading demand. In a small-scale culture mode, a sterile tube sealing machine can be used to aseptically seal the second flow path and the second circulation flow path at the same time, and replace a new harvest container and the corresponding flow path. The harvest container is directly given to the downstream for the next work. In a large-scale culture mode, liquid storage tanks and culture tanks are often used, and the harvested target protein can be directly transported to the downstream through a pipeline using methods such as quick-release tubes for subsequent work.
[0096] Preferably, a liquid storage bag is provided in the third liquid storage container, and the components that pass through the second-stage filtration membrane are stored in the liquid storage bag as a recycled culture medium.
[0097] Preferably, after a liquid storage procedure is completed, the third liquid storage container is replaced with a new liquid storage bag, and the liquid storage bag containing the recycled culture medium is collected for standby use.
[0098] In a third aspect, the present invention provides application of the double-column series continuous cell culture system described in the first aspect and / or the double-column series continuous cell culture process described in the second aspect in biopharmaceuticals.
[0099] The numerical range described in the present invention not only includes the point values listed above, but also includes any point values between the above numerical ranges that are not listed. Due to space limitations and for the sake of simplicity, the present invention no longer exhaustively lists the specific point values included in the range.
[0100] In the present invention, the perfusion rate refers to the amount of culture medium passed through (added and removed) from the bioreactor, usually expressed as a fraction or multiple of the working volume in a given time.
[0101] In the present invention, "working volume" refers to the initial culture volume for cell culture, and the culture volume is usually 1 / 2-2 / 3 of the tank volume. In at least one embodiment, the perfusion rate of the basal medium is usually not higher than 2.5 working volumes / day (VVD), such as 0.1 to 1.5 VVD, 0.3 to 1.2 VVD, 0.5 to 2.0 or 0.8 to 2.5 VVD.
[0102] Compared with the prior art, the present invention has the following beneficial effects:
[0103] (1) The CCC process of the present invention can increase the main peak ratio of the product SEC and SDS CaliperNR without reducing the yield, and reduce aggregates or small molecule fragments.
[0104] (2) The biggest advantage of the CCC process of the present invention is that it has an external biological product collection device, which has significant advantages over other patents and has achieved some effects of regulating the quality of the target protein according to experimental data. According to the characteristics of the protein and the support of stability experimental data, the external harvesting container can be placed in an environment and temperature that is more conducive to the stability and long-term preservation of the target protein. This method can improve the quality of the protein and extend the cell culture time, especially for polyclonal antibodies, fusion proteins, enzymes, etc., which have low purity and are extremely unstable, thereby increasing the yield of the protein. Generally speaking, the CCC process of the present invention places the harvesting container containing the biological product at 2-18°C, which is conducive to the stability of the biological product; for some biological products, the temperature is controlled at 2-8°C, and its stability is further improved; without reducing the yield, the product quality is better than that under normal temperature conditions, which is specifically manifested in the higher proportion of the main peak of the product SEC and the lower proportion of polymers, while the main peak of cIEF is higher and the acid peak is lower.
[0105] (3) The CCC process of the present invention can directly add additives to the harvest container to adjust product quality, which is convenient and quick to operate. In more than one case, adding Cystine to the harvest container can adjust the cIEF acidic peak and main peak ratio. This method has obvious advantages for biosimilar drug projects.
[0106] (4) The CCC process of the present invention can reduce the complexity of production operations. For example, the fermentation liquid in the harvest container can be directly used for downstream purification work without centrifugation or membrane bag; it can be harvested in multiple times: when the downstream loading capacity requirements are met, the harvest can be carried out, and the downstream fillers can be used multiple times, which can reduce the downstream costs to a certain extent and increase the overall output of the downstream.
[0107] (5) The CCC process of the present invention uses two culture medium recycling methods, which can save the cost of using fresh culture medium while ensuring normal cell growth, protein production and protein quality, thereby significantly reducing the cost per unit protein. BRIEF DESCRIPTION OF THE DRAWINGS
[0108] Figure 1 It is a connection diagram of each part in the culture system in Example 1. In the figure, 1, first liquid storage container, 5, first flow path, 7, first circulation flow path, 8, second flow path, 9, second circulation flow path, 10, cell culture container, 11, harvest container, 12, first stage filter column, 13, second stage filter column, 14, third liquid storage container, 16, third flow path, 17, regulating flow path, 19, first sterile feed flow path, 20, scale; V1, valve, P1, pump one, P2, pump two, P3, pump three.
[0109] Figure 2It is a connection diagram of each part in the process flow in Example 2. In the figure, 1, first liquid storage container, 5, first flow path, 6, fourth flow path, 7, first circulation flow path, 8, second flow path, 9, second circulation flow path, 10, cell culture container, 11, harvest container, 12, first stage filter column, 13, second stage filter column, 14, third liquid storage container, 15, second liquid storage container, 16, third flow path, 17, regulating flow path, 19, first sterile feed flow path, 20, scale; V1, V2 are valves, P1, pump one, P2, pump two, P3, pump three, P4, pump four.
[0110] Figure 3 It is a connection diagram of each part in the process flow in Example 3. In the figure, 1, first liquid storage container, 5, first flow path, 6, fourth flow path, 7, first circulation flow path, 8, second flow path, 9, second circulation flow path, 10, cell culture container, 11, harvest container, 12, first stage filter column, 13, second stage filter column, 14, third liquid storage container, 15, second liquid storage container, 16, third flow path, 17, regulating flow path, 18, second sterile feed flow path, 19, first sterile feed flow path, 20, scale; V1, V2 are valves, P1, pump one, P2, pump two, P3, pump three, P4, pump four.
[0111] Figure 4 is the viable cell density (10 6 / mL) versus process time (days).
[0112] Figure 5 It is the result of the activity (%) of the CCC process and the CFB process in Example 4 versus the process time (days).
[0113] Figure 6 These are the results of glucose concentration and process time (days) for the CCC process and the CFB process in Example 4.
[0114] Figure 7 It is the result of lactic acid production or accumulation of CCC process and CFB process in Example 4 versus process time (days).
[0115] Figure 8 These are the results of the productivity of the CCC process and the CFB process versus the process time (days) in Example 4.
[0116] Fig. 9 These are the results of SDS Caliper NR for the CCC process and the CFB process in Example 4.
[0117] Fig.10 These are the results of SEC for the CCC process and the CFB process in Example 4.
[0118] Fig.11 is the viable cell density (10 6 / mL) versus process time (days).
[0119] Fig.12 It is the result of the activity (%) of the CCC process and the CFB process in Example 5 versus the process time (days).
[0120] Fig.13 These are the results of glucose concentration and process time (days) for the CCC process and the CFB process in Example 5.
[0121] Fig.14 It is the result of the lactic acid production or accumulation of the CCC process and the CFB process in Example 5 versus the process time (days).
[0122] Fig.15 These are the results of the productivity of the CCC process and the CFB process versus the process time (days) in Example 5.
[0123] Fig.16 is the viable cell density of the CCC process and the CFB process in Example 6 (10 6 / mL) versus process time (days).
[0124] Fig.17 It is the result of activity (%) versus process time (days) of CCC process and CFB process in Example 6.
[0125] Fig.18 These are the results of glucose concentration and process time (days) for the CCC process and the CFB process in Example 6.
[0126] Fig.19 It is the result of lactic acid production or accumulation of CCC process and CFB process in Example 6 versus process time (days).
[0127] Fig. 20 These are the results of the productivity of the CCC process and the CFB process versus the process time (days) in Example 6. DETAILED DESCRIPTION
[0128] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0129] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0130] The cell types and target product types that the cell culture process of the present invention is suitable for are shown below.
[0131] Cell type: In principle, cells that can be used to produce products are all cells known to those skilled in the art that have the ability to produce biological products. The cells can be animal cells, in particular mammalian cells. Examples of mammalian cells include CHO (Chinese Hamster Ovary) cells, hybridoma cells, BHK (baby hamster kidney) cells, myeloma cells, human cells, such as HEK-293 cells, human lymphoblastoid cells, E1 immortalized HER cells, mouse cells, such as NS0 cells.
[0132] Commercially available basal media may be used, including but not limited to CD OptiCHO AGT (Invitrogen), CD CHOAGT (Invitrogen), Dynamis AGT medium (Invitrogen), SFM4CHO ADCF (Hyclone), HyCellCHO medium (Hyclone), CDM4MAB (Hyclone), DPM Hyclone ActiPro (Hyclone), Advanced CHO Fed Batch Medium (Sigma).
[0133] Commercially available feed media can be used, including but not limited to CHO CD High Efficiency Feed A (Invitrogen), CHO CD High Efficiency Feed B (Invitrogen), CHO CD High Efficiency Feed C (Invitrogen), Sheff-CHO PLUS PF ACF (FM012) (Kerry), CHO CD High Efficiency Feed A+ (Invitrogen), CHO CD High Efficiency Feed B+ (Invitrogen), CHO CD High Efficiency Feed C+ (Invitrogen), DPM-Cell Feed 7a (Hyclone), DPM-Cell Feed 7b (Hyclone) or FAA01A (Hyclone).
[0134] Antibodies include glycosylated and non-glycosylated immunoglobulins of any isotype or subclass, or antigen binding regions thereof, that compete with intact antibodies for specific binding, unless otherwise specified, including human, humanized, chimeric, multispecific, monoclonal, polyclonal and oligomers or antigen binding fragments thereof. Also included are proteins with antigen binding fragments or regions, such as Fab, Fab', F(ab')2, Fv, diabodies, Fd, dAb, maxibodies, single-chain antibody molecules, complementary determining region (CDR) fragments, scFv, diabodies, triabodies, tetrabodies and polypeptides, which contain at least a portion of an immunoglobulin sufficient to confer specific antigen binding to a target polypeptide. The term "antibody" includes, but is not limited to, antibodies prepared, expressed, prepared or isolated by recombinant methods, such as antibodies isolated from host cells transfected to express the antibody.
[0135] Example 1
[0136] This embodiment provides a double-column series continuous cell culture system, such as Figure 1 As shown, the culture system comprises:
[0137] A cell culture container 10 is provided, wherein the cell culture container 10 is used for cell culture.
[0138] The first-stage filter column 12 has a first-stage filter membrane, which performs membrane separation treatment on the cell suspension extracted from the cell culture container; returns the components blocked by the first-stage filter membrane to the cell culture container 10; and stores the components that pass through the first-stage filter membrane in the harvest container 11; the membrane pore size of the first-stage filter membrane is smaller than the diameter of the cells and larger than the diameter of the target product expressed by the cells; the membrane pore size of the first-stage filter membrane is 0.1-20μm.
[0139] The second filter column 13 has a second filter membrane, which performs membrane separation treatment on the suspension extracted from the harvest container; all components blocked by the second filter membrane are retained in the harvest container 11; components that pass through the second filter membrane are stored as waste liquid; the membrane pore size of the second filter membrane is smaller than the diameter of the target product expressed by the cell. The second filter membrane is an ultrafiltration membrane, and the membrane pore size of the second filter membrane is usually 0-100KD.
[0140] The membrane separation treatment method is a tangential flow method.
[0141] A harvest container 11 is arranged between the first-stage filter column 12 and the second-stage filter column 13. The harvest container 11 is used to store components that pass through the first-stage filter membrane. The second-stage filter membrane performs membrane separation treatment on the suspension extracted from the harvest container 11. The harvest container 11 is provided with a temperature control device and a first sterile feed flow path 19. The temperature of the harvest container 11 is controlled at 2-18°C. The first sterile feed flow path 19 is used to add additives to the harvest container 11.
[0142] The culture system further comprises: a first liquid storage container 1 and a third liquid storage container 14. The first liquid storage container 1 is used to store fresh culture medium; the third liquid storage container 14 is used to store liquid that passes through the second-stage filter membrane, i.e., waste liquid.
[0143] The first liquid storage container 1 is connected to the cell culture container 10 via a first flow path 5, and the flow rate is controlled by a pump P1.
[0144] The cell culture container 10 is provided with a regulating flow path 17 , and the regulating flow path 17 is used to regulate the cell density and viability in the cell culture container; a scale 20 is provided below the cell culture container 10 ; the scale 20 is used to control the total amount of the culture in the cell culture container 10 .
[0145] The cell culture container 10 is connected to the first-stage filter column 12 via a first circulation flow path 7; the first circulation flow path 7 is used to transport the cell suspension from the cell culture container 10 to the first-stage filter column 12, and to return the components blocked by the first-stage filter membrane to the cell culture container 10.
[0146] The first-stage filter column 12 is connected to the harvest container through the second flow path 8, and the flow rate is controlled by the pump P2.
[0147] The harvest container 11 is connected to the second-stage filter column 13 via a second circulation flow path 9; the second circulation flow path 9 is used to transport the suspension from the harvest container 11 to the second-stage filter column 13, and to return the components blocked by the second-stage filter membrane to the harvest container 11.
[0148] The second-stage filter column 13 is connected to the third liquid storage container 14 via a third flow path 16, and the flow rate is controlled by a pump P3.
[0149] Example 2
[0150] This embodiment provides a double-column series continuous cell culture system, such as Figure 2 As shown, the culture system comprises:
[0151] A cell culture container 10 is provided, wherein the cell culture container 10 is used for cell culture.
[0152] The first-stage filter column 12 has a first-stage filter membrane, which performs membrane separation treatment on the cell suspension extracted from the cell culture container 10; returns the components blocked by the first-stage filter membrane to the cell culture container 10; and stores the components that pass through the first-stage filter membrane in the harvest container 11; the membrane pore size of the first-stage filter membrane is smaller than the diameter of the cells and larger than the diameter of the target product expressed by the cells; the membrane pore size of the first-stage filter membrane is 0.1-20μm.
[0153] The second filter column 13 has a second filter membrane, which performs membrane separation treatment on the suspension extracted from the harvest container 11; all components blocked by the second filter membrane are retained in the harvest container 11; the components that pass through the second filter membrane are stored as a recycling culture medium; the pore size of the second filter membrane is smaller than the diameter of the target product expressed by the cells. The second filter membrane is an ultrafiltration membrane, and the pore size of the second filter membrane is usually 0-100KD.
[0154] The membrane separation treatment method is a tangential flow method.
[0155] A harvest container 11 is arranged between the first-stage filter column 12 and the second-stage filter column 13. The harvest container 11 is used to store components that pass through the first-stage filter membrane. The second-stage filter membrane performs membrane separation treatment on the suspension extracted from the harvest container 11. The harvest container 11 is provided with a temperature control device and a first sterile feed flow path 19. The temperature of the harvest container 11 is controlled at 2-18°C. The first sterile feed flow path 19 is used to add additives to the harvest container 11.
[0156] The culture system further comprises: a first liquid storage container 1, a second liquid storage container 15, and a third liquid storage container 14. The first liquid storage container 1 is used to store fresh culture medium; the second liquid storage container 15 is used to store recycled culture medium; and the third liquid storage container 14 is used to store components that pass through the second-stage filtration membrane.
[0157] The first liquid storage container 1 is connected to the cell culture container 10 through a first flow path 5, and the flow rate is controlled by a pump P1; the second liquid storage container 15 is connected to the cell culture container 10 through a fourth flow path 6, and the flow rate is controlled by a pump P4.
[0158] The cell culture container 10 is provided with a regulating flow path 17 , and the regulating flow path 17 is used to regulate the cell density and viability in the cell culture container 10 ; a scale 20 is provided below the cell culture container 10 ; the scale 20 is used to control the total amount of the culture in the cell culture container 10 .
[0159] The cell culture container 10 is connected to the first-stage filter column 12 via a first circulation flow path 7; the first circulation flow path 7 is used to transport the cell suspension from the cell culture container 10 to the first-stage filter column 12, and to return the components blocked by the first-stage filter membrane to the cell culture container 10.
[0160] The first-stage filter column 12 is connected to the harvest container 11 via a second flow path 8, and the flow rate is controlled by a pump P2.
[0161] The harvest container 11 is connected to the second-stage filter column 13 via a second circulation path 9 ; the second circulation path 9 is used to transport the suspension from the harvest container 11 to the second-stage filter column 13 , and to return the components blocked by the second-stage filter membrane to the harvest container 11 .
[0162] The second-stage filter column 13 is connected to the third liquid storage container 14 via a third flow path 16, and the flow rate is controlled by a pump P3.
[0163] This embodiment provides a double-column series continuous cell culture process. The connection diagram of each part in the process flow is shown in Figure 2 , the culture process comprises the following steps:
[0164] This embodiment provides a method of recycling the culture medium in batches. From the start of pump 2 (P2), liquid will flow into the container containing the recycled culture medium. The cycle period is 2-21 days. Generally, 3-6 days is one cycle period. When the culture period is long, the time of each cycle period can be adjusted according to the actual situation. After 3-6 days, a certain amount of liquid that has passed through the second-stage filter column 13 (hollow fiber column) will be stored in the third liquid storage container 14. The liquid in the container 14 is transferred to the position of the second liquid storage container 15, and a new liquid storage bag is placed in the third liquid storage container 14 to continue to store the liquid that has passed through the second-stage filter column 13 for the next liquid storage procedure. In the case of this culture medium reuse, the first liquid storage container 1 containing fresh culture medium and the second liquid storage container 15 containing recycled culture medium are operated at the same time, that is, pump 1 P1 and pump 4 P4 work at the same time, and the total amount of liquid that is passed into the tank through the first flow path 5 and the fourth flow path 6 by pump 1 P1 plus pump 4 P4 is consistent with the total amount before the culture medium is reused. The ratio of the liquid pumped into the tank through the first flow path 5 and the fourth flow path 6 will change according to the number of cycles of the recycled culture medium used. Generally, the first cycle P1:P4=1:9-5:5; the second cycle P1:P4=2:8-7:3; the third cycle P1:P4=3:7-9:1 and so on. It can also be adjusted according to the cell viability, the amount of metabolic waste and the pore size of the second-stage filter column 13.
[0165] Example 3
[0166] This embodiment provides a double-column continuous cell culture system. The difference between the culture system and Example 1 is that a second sterile feed flow path 18 is provided on the third liquid storage container 14, and the second sterile feed flow path 18 is used to add nutrients filtered out by the second-stage filter membrane to the third liquid storage container 14.
[0167] This embodiment provides a double-column series continuous cell culture process. The connection diagram of each part in the process flow is shown in Figure 3 , the culture process comprises the following steps:
[0168] This embodiment provides a method of recycling the culture medium in batches. Liquid will flow into the container containing the recycled culture medium from the start of pump 2 P2. The cycle period is 2-21 days. Usually, 3-6 days is one cycle. When the culture period is long, the time of each cycle can be adjusted according to the actual situation. After 3-6 days, a certain amount of liquid that has passed through the second-stage filter column 13 (hollow fiber column) will be stored in the third liquid storage container 14. According to the pore size of the secondary filter membrane, some nutrients filtered out by the secondary filter membrane can be added, including but not limited to: glucose, P188, CB5 or glutamine.
[0169] Since the culture medium used in this culture medium recycling is added with the necessary factors for cell growth used by the cells and filtered out by the second-stage filter column 13, this recycling method will not use fresh culture medium 1 when enough liquid for one cycle is collected (3-6 days), that is, compared with the culture medium recycling method of Example 2, only the pump 4 P4 is running, and only the fourth flow path 6 pumps the recycled culture medium into the tank for cell use. Valve V1 and pump 1 P1 are closed in this culture medium recycling situation.
[0170] The cells used in the following examples are mammalian cell lines, and the detailed information is as follows:
[0171] CHO-K1 host cells were purchased from ATCC (ATCC No.: CCL 61) and contain Blasticidin and Zeocin resistance markers, respectively. Liposomes were used for stable transfection. After transfection, the cells were passaged in a selective medium (CD CHO medium containing 9 μg / mL Blasticidin and 400 μg / mL Zeocin) for pool selection. After about 2 weeks of pool selection, the pool was cloned by FACS sorting. The target clones A / B / C were screened out by flow-batch culture in a centrifuge tube. Clone A was used for Example 1, clone B was used for Example 2, and clone C was used for Example 3.
[0172] Example 4
[0173] In this example, clone A was used to directly compare the performance of the two-column model in series (CCC) and the ultra-high concentrated fed-batch culture mode (CFB).
[0174] Cultivation process of double column series model (CCC):
[0175] The CCC process was carried out in a 3L Applikon vessel, with the temperature controlled at 36.5°C, pH range of approximately 6.70-7.10, and DO air saturation of 40% using a Finesse controller. Cells were retained using a 0.2 μm cutoff hollow fiber filter (Repligen) operated in ATF flow mode with an ATF-2H system (Refine Technology), and bioproducts were retained in a collection bottle using a 50 KD cutoff hollow fiber filter (Cytiva).
[0176] Cultivation was started at 0.40×106 cells / mL in Actipro medium supplemented with 4.0 mM L-glutamine and 0.3% CB7b. From day 3, about 10-100 ppm of defoamer was added daily. From day 3, basal medium (Actipro supplemented with 4.0 mM L-glutamine and 0.3% CB7b) was perfused at 0.5 VVD, and on day 4, VVD was increased from 0.5 to 1.0. From day 5 to the end of the culture, feed medium CB7a was perfused at a rate of 3.0% of the basal medium.
[0177] From day 4 to the end of the culture, the perfusion rate of Actipro medium was maintained at 1.0 VVD. On day 5, the temperature was shifted from 36.5°C to 33.0°C and maintained at 33.0°C until the end of the culture. From day 15, about 20ppm-120ppm of antifoam was added every day. The biological products produced by the cells were harvested through an external collection bottle. During the entire culture process, the cells were retained in the bioreactor and the cells were not discharged.
[0178] Cultivation process of ultra-high concentrated fed-batch culture mode (CFB):
[0179] Process B was performed using a Finesse controller to control the temperature at 36.5°C, pH range of approximately 6.70-7.10, and DO air saturation of 40%. The concentrated fed-batch process was operated identically to Process A except for the cut-off hollow fiber filtration (Cytiva), which had a pore size of 50 KD to retain both cells and biologics in the medium.
[0180] Example 5
[0181] In this embodiment, clone B was used to compare the performance of the double-column series model (CCC) and the ultra-high concentrated fed-batch culture mode (CFB), and a series of optimization work was done on the CCC process. The optimization direction mainly acted on the harvest container 11, mainly including: placing the harvest container at room temperature, placing the harvest container in a refrigerator at 2-8 degrees, purifying the proteins "D7-D14&D14-D21" in the harvest container in batches, concentrating the proteins in the harvest container on the day of harvest, adding HAC-Tris buffer to the harvest container in advance when the harvest container is placed at room temperature, and adding cysteine to the harvest container on the day of harvest.
[0182] Cultivation process of double column series model (CCC):
[0183] The CCC process was carried out in a 3L Applikon vessel, with the temperature controlled at 36.5°C, pH range of approximately 6.80-7.20, and DO air saturation of 40% using a Finesse controller. Cells were retained using a 0.2 μm cutoff hollow fiber filter (Repligen) operated in ATF flow mode with an ATF-2H system (Refine Technology), and bioproducts were retained in a collection bottle using a 50 KD cutoff hollow fiber filter (Cytiva).
[0184] In Highpro-100 medium supplemented with 4.0 mM L-glutamine and 0.3% CB7b, 0.40 × 10 6 Cells / mL were used to start the culture. From the start of inoculation, about 10-100 ppm of defoamer was added every day. From the 4th day, basal medium (Highpro-100 supplemented with 4.0 mM L-glutamine and 0.3% CB7b) was perfused at 1.0 VVD until the end of the culture. From the 4th day to the end of the culture, feed medium CB7a was perfused at a rate of 3.0%-12% of the basal medium.
[0185] On the 5th day, the temperature was shifted from 36.5°C to 33.0°C and maintained at 33.0°C until the culture was terminated. From the 8th day, about 20ppm-120ppm of antifoam was added every day. The biological products produced by the cells were harvested through an external collection bottle. During the entire culture process, the cells were retained in the bioreactor and the cells were not discharged.
[0186] Cultivation process of ultra-high concentrated fed-batch culture mode (CFB):
[0187] Process B was performed using a Finesse controller to control the temperature at 36.5°C, pH range of approximately 6.70-7.10, and DO air saturation of 40%. The concentrated fed-batch process was operated identically to Process A except for the cut-off hollow fiber filtration (Cytiva), which had a pore size of 50 KD to retain both cells and biologics in the medium.
[0188] Example 6
[0189] In this embodiment, clone C was used to compare the performance of a double-column series model (CCC) and an ultra-high concentrated fed-batch culture mode (CFB), and a series of optimization work was done on the CCC process. The optimization direction mainly acted on the harvest container 11, mainly including: placing the harvest container at room temperature, placing the harvest container in a refrigerator at 2-8 degrees, purifying the proteins "D7-D14&D14-D21" in the harvest container in batches, concentrating the proteins in the harvest container on the day of harvest, adding HAC-Tris buffer to the harvest container in advance when the harvest container was placed at room temperature, and adding cysteine to the harvest container on the day of harvest.
[0190] Cultivation process of double column series model (CCC):
[0191] The CCC process was carried out in a 3L Applikon vessel, with the temperature controlled at 36.5°C, pH range of approximately 6.80-7.20, and DO air saturation of 40% using a Finesse controller. Cells were retained using a 0.2 μm cutoff hollow fiber filter (Repligen) operated in ATF flow mode with an ATF-2H system (Refine Technology), and bioproducts were retained in a collection bottle using a 50 KD cutoff hollow fiber filter (Cytiva).
[0192] In Highpro-100 medium supplemented with 4.0 mM L-glutamine and 0.3% CB7b, 0.40 × 10 6 Cells / mL were used to start the culture. From the start of inoculation, about 10-100 ppm of defoamer was added every day. From the 4th day, basal medium (Highpro-100 supplemented with 4.0 mM L-glutamine and 0.3% CB7b) was perfused at 1.0 VVD until the end of the culture. From the 4th day to the end of the culture, feed medium CB7a was perfused at a rate of 3.0%-12% of the basal medium.
[0193] On the 5th day, the temperature was shifted from 36.5°C to 33.0°C and maintained at 33.0°C until the culture was terminated. From the 8th day, about 20ppm-120ppm of antifoam was added every day. The biological products produced by the cells were harvested through an external collection bottle. During the entire culture process, the cells were retained in the bioreactor and the cells were not discharged.
[0194] Cultivation process of ultra-high concentrated fed-batch culture mode (CFB):
[0195] Process B was performed using a Finesse controller to control the temperature at 36.5°C, pH range of approximately 6.70-7.10, and DO air saturation of 40%. The concentrated fed-batch process was operated identically to Process A except for the cut-off hollow fiber filtration (Cytiva), which had a pore size of 50 KD to retain both cells and biologics in the medium.
[0196] The experimental results are shown in Tables 1 to 4. Table 1 shows the results of SDS Caliper NR and SEC for the CCC process under various conditions and the CFB process in Example 2 (Example 5). Table 2 shows the results of CIEF for the CCC process under various conditions and the CFB process in Example 2 (Example 5). Table 3 shows the results of SDS Caliper NR and SEC for the CCC process under various conditions and the CFB process in Example 3 (Example 6). Table 4 shows the results of CIEF for the CCC process under various conditions and the CFB process in Example 3 (Example 6).
[0197] Table 1
[0198]
[0199] Table 2
[0200]
[0201]
[0202] Table 3
[0203]
[0204] Table 4
[0205]
[0206] The experimental results are shown in Figure 4-Figure 20 .from Figure 4 , Figure 5 , Figure 6 , Figure 7 , Figure 8 , Fig. 9 , Fig.10It can be seen that under certain circumstances, compared with CFB, the CCC process can obtain higher yields while increasing the main peak ratio of the SDS Caliper NR of the product and improving the purity of the target product.
[0207] from Fig.11 , Fig.12 , Fig.13 , Fig.14 , Fig.15 As shown in Table 1 and Table 2, compared with CFB, the CCC process can obtain higher yields while increasing the main peak ratio of the product in SEC and SDS Caliper NR and reducing aggregates or small molecule fragments. From the results of SEC and SDS Caliper NR, it can be seen that no matter which method is used, adding Cystine to the collection device on the harvest day, placing the harvest container at different temperatures, and adding pH5.5HAC&Tris buffer solution to the harvest container before the start of harvest, the purity of the CCC process is higher than that of the CFB process. From the results of CIEF, it can be seen that adding Cystine to the collection device on the harvest day, placing the harvest container at different temperatures, and adding pH5.5HAC&Tris buffer solution to the harvest container before the start of harvest can adjust the cIEF acidic peak and the main peak ratio. This method has obvious advantages in protein quality regulation for biosimilars.
[0208] from Fig.16 , Fig.17 , Fig.18 , Fig.19 , Fig. 20 As shown in Tables 3 and 4, compared with CFB, the CCC process can obtain higher yields and, under certain conditions, can increase the main peak ratio of the product in SEC and SDS Caliper NR, and reduce aggregates or small molecule fragments. From the results of SEC and SDS Caliper NR, it can be seen that no matter which method is used, adding Cystine to the collection device on the harvest day, placing the harvest container at different temperatures, and adding pH5.5 HAC&Tris buffer solution to the harvest container before the start of harvest, the purity of the CCC process is higher than that of the CFB process under certain conditions. From the results of CIEF, it can be seen that adding Cystine to the collection device on the harvest day, placing the harvest container at different temperatures, and adding pH5.5 HAC&Tris buffer solution to the harvest container before the start of harvest can adjust the cIEF acidic peak and the main peak ratio. This method has obvious advantages in protein quality regulation for biosimilars.
[0209] In summary, the present invention uses two culture medium recycling methods to ensure normal cell growth, unchanged protein yield and protein quality, while saving the cost of using fresh culture medium and significantly reducing the cost per unit protein. The culture medium recycling reflux method of the present invention has important application value in biopharmaceuticals.
[0210] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.
Claims
1. A double-column series continuous cell culture system, It is characterized in that The culture system comprises: A cell culture container, wherein the cell culture container is used for cell culture; A first-stage filter column, comprising a first-stage filter membrane, wherein the pore size of the first-stage filter membrane is smaller than the diameter of the cells and larger than the diameter of the target product expressed by the cells; the pore size of the first-stage filter membrane is 0.1-20 μm; The second-stage filter column has a second-stage filter membrane, the pore size of which is smaller than the diameter of the target product expressed by the cells; the second-stage filter membrane is an ultrafiltration membrane, and the pore size of which is 0-100KD; A harvest container is provided between the first-stage filter column and the second-stage filter column, the harvest container is used to store components that have passed through the first-stage filter membrane and have not passed through the second-stage filter membrane, and the second-stage filter membrane performs membrane separation treatment on the suspension extracted from the harvest container; a temperature control device and a first sterile feed flow path are provided on the harvest container; the first sterile feed flow path is used to add additives to the harvest container; The culture system further comprises: a first liquid storage container, a second liquid storage container or a third liquid storage container, or a combination thereof; The third liquid storage container is used to store the components that pass through the second-stage filtration membrane; the third liquid storage container is provided with a second sterile feed flow path, and the second sterile feed flow path is used to add nutrients to the third liquid storage container.
2. The double-column series cell continuous culture system according to claim 1, It is characterized in that The temperature of the harvesting container is controlled at 2-18°C; Preferably, the membrane separation treatment is carried out in a tangential flow manner; Preferably, the additive comprises: any one or a combination of at least two of a protective agent, a neutral buffer system, an acidic buffer system, an alkaline buffer system or an amino acid; Preferably, the protective agent is selected from any one or a combination of at least two of sucrose, PS80, P188, sodium salt, sulfate or ammonium salt; Preferably, the neutral buffer system is PB; Preferably, the acidic buffer system is selected from citric acid or acetic acid; Preferably, the alkaline buffer system is selected from Tris-Hac or Tris-HCl; Preferably, the amino acid is selected from arginine or histidine.
3. The double-column series cell continuous culture system according to claim 1 or 2, It is characterized in that The first liquid storage container is used to store fresh culture medium; Preferably, the first liquid storage container is connected to the cell culture container via a first flow path, and the flow rate is controlled by a pump 1; Preferably, the second liquid storage container is used to store the recycled culture medium; Preferably, the second liquid storage container is connected to the cell culture container via a fourth flow path, and the flow rate is controlled by a pump four; Preferably, the nutrient components include: any one or a combination of at least two of carbohydrates, P188, CB5, glutamine, glutamic acid, HT, amino acids, metal ions, lipid precursors, nucleic acid precursors, pH buffers or cell protectants; Preferably, the cell protectant is selected from PEG or a nonionic surfactant.
4. The double-column series continuous cell culture system according to any one of claims 1 to 3, It is characterized in that The cell culture container is provided with a regulating flow path, and the regulating flow path is used to regulate the cell density and viability in the cell culture container; Preferably, a scale is provided below the cell culture container; the scale is used to control the total amount of the culture in the cell culture container; Preferably, the cell culture container is connected to the first-stage filtration column via a first circulation flow path; Preferably, the first circulation flow path is used to transport the cell suspension from the cell culture container to the first-stage filtration column, and to return the components blocked by the first-stage filtration membrane to the cell culture container; Preferably, the first-stage filtration column is connected to the harvesting container via a second flow path, and the flow rate is controlled by a second pump; Preferably, the harvest container is connected to the second-stage filtration column via a second circulation flow path; Preferably, the second circulation flow path is used to transport the suspension from the harvest container to the second-stage filtration column, and to return the components blocked by the second-stage filtration membrane to the harvest container; Preferably, the second-stage filter column is connected to the third liquid storage container via a third flow path, and the flow rate is controlled by a third pump.
5. A double-column series continuous cell culture process, It is characterized in that The culture process comprises: The cells are inoculated into a cell culture container for continuous perfusion culture; The first-stage filtration membrane separation process is started, and the cell suspension extracted from the cell culture container is subjected to membrane separation treatment using the first-stage filtration membrane, and the components blocked by the first-stage filtration membrane are returned to the cell culture container; the components that pass through the first-stage filtration membrane are stored in a harvest container; the pore size of the first-stage filtration membrane is smaller than the diameter of the cell and larger than the diameter of the target product expressed by the cell; the pore size of the first-stage filtration membrane is 0.1-20 μm; The temperature of the harvest container is controlled by a temperature control device, and the additive is added to the harvest container through the first sterile feed flow path; The second-stage filtration membrane separation process is started, and the suspension extracted from the harvest container is subjected to membrane separation treatment using the second-stage filtration membrane, components blocked by the second-stage filtration membrane are returned to the harvest container, and components passing through the second-stage filtration membrane are stored as recycled culture medium; the membrane pore size of the second-stage filtration membrane is smaller than the diameter of the target product expressed by the cells; the second-stage filtration membrane is an ultrafiltration membrane, and the membrane pore size of the second-stage filtration membrane is 0-100KD.
6. The double-column series cell continuous culture process according to claim 5, It is characterized in that When the working volume of the cell culture container is greater than the initial culture volume, starting the first stage filtration membrane separation process; Preferably, when the liquid volume in the harvest container reaches 0.5-2 working volumes, the second stage filtration membrane separation process is started; Preferably, the ambient temperature of the harvesting container is controlled at 2-18°C; Preferably, the membrane separation treatment is carried out in a tangential flow manner; Preferably, the additive comprises: any one or a combination of at least two of a protective agent, a neutral buffer system, an acidic buffer system, an alkaline buffer system or an amino acid; Preferably, the protective agent is selected from any one or a combination of at least two of sucrose, PS80, P188, sodium salt, sulfate or ammonium salt; Preferably, the neutral buffer system is PB; Preferably, the acidic buffer system is selected from citric acid or acetic acid; Preferably, the alkaline buffer system is selected from Tris-Hac or Tris-HCl; Preferably, the amino acid is selected from arginine or histidine.
7. The double-column series continuous cell culture process according to claim 5 or 6, It is characterized in that The concentration of the target product in the harvest container is controlled by: The working speed of the pump in the second-stage filtration membrane separation process is controlled to be greater than that in the first-stage filtration membrane separation process, and the concentration of the target product in the harvest container increases; Or, the working speed of the pump in the second-stage filtration membrane separation process is controlled to be lower than that in the first-stage filtration membrane separation process, so that the concentration of the target product in the harvest container is reduced; After the concentration of the target product reaches the desired concentration, the working speed of the pump in the second-stage filtration membrane separation process is controlled to be equal to that in the first-stage filtration membrane separation process to keep the volume of the suspension in the harvest container constant.
8. The continuous cell culture process of double columns in series according to any one of claims 5 to 7, It is characterized in that The perfusion medium used in the perfusion continuous culture is a fresh medium or a combination of a fresh medium and a recycled medium; Preferably, in the first culture cycle, the perfusion continuous culture is perfused with fresh culture medium; from the second culture cycle to the end of the culture, the perfusion continuous culture is performed with a combination of fresh culture medium and recycled culture medium; Preferably, when a combination of fresh culture medium and recycled culture medium is used for perfusion continuous culture, the perfusion rate ratio of fresh culture medium to recycled culture medium in the first cycle is (1:9)-(5:5); the perfusion rate ratio in the second cycle is (2:8)-(7:3); the perfusion rate ratio in the third cycle is (3:7)-(9:1); Preferably, nutrients are also added to the recycling culture medium; Preferably, the nutrient components include: any one or a combination of at least two of carbohydrates, P188, CB5, glutamine, glutamic acid, HT, amino acids, metal ions, lipid precursors, nucleic acid precursors, pH buffers or cell protectants; Preferably, the cell protectant is selected from PEG or a nonionic surfactant; Preferably, the amount of the nutrients added is calculated based on the volume of the circulating culture medium.
9. The continuous cell culture process of double columns in series according to any one of claims 5 to 8, It is characterized in that The initial density of cells inoculated in the cell culture container ranges from (0.1-4.0)×10 6 viable cells / mL; Preferably, the method further comprises adding a defoaming agent to the bioreactor before the inoculation or during the culture process; Preferably, 0-120 ppm of defoaming agent is added every day during the perfusion continuous culture process; Preferably, during the perfusion continuous culture process, when the oxygen flow rate reaches 0.3-0.8 VVM, a differentiator is used for control.
10. The continuous cell culture process of double columns in series according to any one of claims 5 to 9, It is characterized in that Based on the density of cells and the viability of cells in the cell culture container, the cells are allowed to flow out of the cell culture container by controlling and adjusting the flow path.
11. The continuous cell culture process of double columns in series according to any one of claims 5 to 10, It is characterized in that After the harvest container and the flow path connected to the harvest container are sealed aseptically and replaced with a new harvest container and the corresponding flow path, the harvest container is directly connected to the downstream processing process; Preferably, the harvesting container is a sterile container that can store liquid; Preferably, the types of the harvesting container include: a liquid storage tank, a culture tank, a sterile bottle or a sterile bag; Preferably, the third liquid storage container is provided with a liquid storage bag, and the components that pass through the second-stage filter membrane are stored in the liquid storage bag as a recycling culture medium; Preferably, after a liquid storage procedure is completed, the third liquid storage container is replaced with a new liquid storage bag, and the liquid storage bag containing the recycled culture medium is collected for standby use.
12. Use of the double-column continuous cell culture system according to any one of claims 1 to 4 and / or the double-column continuous cell culture process according to any one of claims 5 to 11 in biopharmaceuticals.
